Suchergebnisse - Tong‐Ming Fu
- Treffer 1 - 20 von 39
- Zur nächsten Seite
-
1
Antibody therapies for the prevention and treatment of viral infections von Georgina To’a Salazar, Ningyan Zhang, Tong‐Ming Fu, Zhiqiang An
Veröffentlicht 2017Artigo -
2
Natural killer cells in cancer biology and therapy von Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, Zhi-Ming Shao
Veröffentlicht 2020Revisão -
3
-
4
-
5
Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge von Tong‐Ming Fu, Liming Guan, Arthur Friedman, Timothy Schofield, Jeffrey B. Ulmer, Margaret A. Liu, John Donnelly
Veröffentlicht 1999Artigo -
6
-
7
Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity von Joseph E. Blaney, Eri Nobusawa, Michael A. Brehm, Robert H. Bonneau, Lawrence M. Mylin, Tong‐Ming Fu, Yoshihiro Kawaoka, Satvir S. Tevethia
Veröffentlicht 1998Artigo -
8
-
9
-
10
Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes von Tong‐Ming Fu, Jeffrey B. Ulmer, Michael J. Caulfield, R. Randall Deck, Arthur Friedman, Su Wang, Xu Liu, John Donnelly, Margaret A. Liu, Hans Wigzell
Veröffentlicht 1997Artigo -
11
Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine von Rebecca T. Emeny, Cosette M. Wheeler, Kathrin U. Jansen, William C. Hunt, Tong‐Ming Fu, Judith F. Smith, Stefani A. MacMullen, Mark T. Esser, Xavier Paliard
Veröffentlicht 2002Artigo -
12
Putative Immunodominant Human Immunodeficiency Virus-Specific CD8<sup>+</sup>T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I Haplotype von Michael R. Betts, Joseph P. Casazza, Brent A. Patterson, Shar L. Waldrop, Wendy L. Trigona, Tong‐Ming Fu, Florian Kern, Louis J. Picker, Richard A. Koup
Veröffentlicht 2000Artigo -
13
Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus von Tong‐Ming Fu, Daniel C. Freed, Melanie Horton, Fan Jiang, Michael Citron, Joseph G. Joyce, Victor M. Garsky, Danilo R. Casimiro, Qinjian Zhao, John W. Shiver, Xiaoping Liang
Veröffentlicht 2008Artigo -
14
Protective CD4<sup>+</sup>and CD8<sup>+</sup>T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA von Jeffrey B. Ulmer, Tong‐Ming Fu, R. Randall Deck, Arthur Friedman, Liming Guan, Corrille M. DeWitt, Xu Liu, Su Wang, Margaret A. Liu, John Donnelly, Michael J. Caulfield
Veröffentlicht 1998Artigo -
15
Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans von Jennifer A. Jenks, Cody S. Nelson, Hunter Roark, Matthew L. Goodwin, Robert F. Pass, David I. Bernstein, Emmanuel B. Walter, Kathryn M. Edwards, Dai Wang, Tong‐Ming Fu, Zhiqiang An, Cliburn Chan, Sallie R. Permar
Veröffentlicht 2020Artigo -
16
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination von Fengsheng Li, Daniel C. Freed, Aimin Tang, Richard R. Rustandi, Matthew C. Troutman, Amy S. Espeseth, Ningyan Zhang, Zhiqiang An, Michael A. McVoy, Hua Zhu, Sha Ha, Dai Wang, Stuart P. Adler, Tong‐Ming Fu
Veröffentlicht 2017Artigo -
17
A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaque... von Stefania Capone, Annalisa Meola, Bruno Bruni Ercole, Alessandra Vitelli, Monica Pezzanera, Lionello Ruggeri, M E Davies, Rosalba Tafi, Claudia Santini, Alessandra Luzzago, Tong‐Ming Fu, Andrew Bett, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia, Antonella Folgori
Veröffentlicht 2006Artigo -
18
Simian Immunodeficiency Virus (SIV)<i>gag</i>DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Inf... von Michael A. Egan, William A. Charini, Marcelo J. Kuroda, Jörn E. Schmitz, Paul Rácz, Klara Tenner‐Racz, Kelledy Manson, Michael S. Wyand, Michelle A. Lifton, Christie E. Nickerson, Tong‐Ming Fu, John W. Shiver, Norman L. Letvin
Veröffentlicht 2000Artigo -
19
Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors von Danilo R. Casimiro, Andrew J. Bett, Tong‐Ming Fu, Mary-Ellen Davies, Aimin Tang, Keith A. Wilson, Minchun Chen, Romnie Long, Troy W. McKelvey, Michael Chastain, Sanjay Gurunathan, Jim Tartaglia, Emilio A. Emini, John W. Shiver
Veröffentlicht 2004Artigo -
20
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects von Stuart P. Adler, Nicole Lewis, Anthony Conlon, Mark P. Christiansen, Mohamed Al‐Ibrahim, Richard Rupp, Tong‐Ming Fu, Oliver Bautista, Huaping Tang, Dai Wang, A. Fisher, Timothy D. Culp, Rituparna Das, Karen Beck, Gretchen Tamms, Luwy Musey
Veröffentlicht 2019Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Immunology
Biology
Virology
Virus
Immune system
Antibody
Genetics
Medicine
Gene
In vitro
Biochemistry
CD8
Cytotoxic T cell
Epitope
Vaccination
Viral disease
CTL*
DNA vaccination
Human cytomegalovirus
Immunity
Immunization
Antigen
Cellular immunity
Neutralizing antibody
Recombinant DNA
Viral replication
Cytomegalovirus
Herpesviridae
Disease
Immunogenicity